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Abstract
Background: The infection and virulence functions of diverse plant and animal pathogens that
possess quorum sensing systems are regulated by N-acylhomoserine lactones (AHLs) acting as
signal molecules. AHL-acylase is a quorum quenching enzyme and degrades AHLs by removing the
fatty acid side chain from the homoserine lactone ring of AHLs. This blocks AHL accumulation and
pathogenic phenotypes in quorum sensing bacteria.
Results: An aac gene of undemonstrated function from Ralstonia solanacearum GMI1000 was
cloned, expressed in Escherichia coli; it inactivated four AHLs that were tested. The sequence of the
795 amino acid polypeptide was considerably similar to the AHL-acylase from Ralstonia sp. XJ12B
with 83% identity match and shared 39% identity with an aculeacin A acylase precursor from the
gram-positive actinomycete Actinoplanes utahensis. Aculeacin A is a neutral lipopeptide antibiotic
and an antifungal drug. An electrospray ionisation mass spectrometry (ESI-MS) analysis verified that
Aac hydrolysed the amide bond of AHL, releasing homoserine lactone and the corresponding fatty
acids. However, ESI-MS analysis demonstrated that the Aac could not catalyze the hydrolysis of the
palmitoyl moiety of the aculeacin A. Moreover, the results of MIC test of aculeacin A suggest that
Aac could not deacylate aculeacin A. The specificity of Aac for AHLs showed a greater preference
for long acyl chains than for short acyl chains. Heterologous expression of the aac  gene in
Chromobacterium violaceum CV026 effectively inhibited violacein and chitinase activity, both of which
were regulated by the quorum-sensing mechanism. These results indicated that Aac could control
AHL-dependent pathogenicity.
Conclusion: This is the first study to find an AHL-acylase in a phytopathogen. Our data provide
direct evidence that the functioning of the aac gene (NP520668) of R. solanacearum GMI1000 is via
AHL-acylase and not via aculeacin A acylase. Since Aac is a therapeutic potential quorum-quenching
agent, its further biotechnological applications in agriculture, clinical and bio-industrial fields should
be evaluated in the near future.
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Background
A bacterial cell-to-cell communication mechanism, quo-
rum sensing, is a regulatory process that utilises small, dif-
fusible signal molecules to modulate specific gene
expression in a population density-dependent manner
[1,2]. Diverse gram-negative bacteria can synthesise N-
acyl-homoserine lactones (AHLs) as quorum-sensing sig-
nal molecules by means of LuxI-type AHL synthases [3].
These quorum-sensing signal molecules share identical
homoserine lactone moieties but vary in length or the car-
bon substitution on the third position on the acyl side
chain. As the population density increases, the AHLs bind
to LuxR transcriptional regulators; then, the LuxR/AHL
complexes regulate the expression of the target genes. The
AHL-mediated quorum sensing mechanisms are highly
conserved and could regulate infections and virulence fac-
tors in several human and plant pathogenic bacteria, such
as Chromobacterium violaceum, Burkholderia cepacia, Erwinia
carotovora, Brucella melitensis, and Pseudomonas aeruginosa
[3-5]. Recently, the AHL-mediated quorum-sensing sys-
tems have been viewed as new targets for anti-infective
therapies. In contrast to traditional drug designs that are
either bactericidal or bacteriostatic, the disruption of the
AHL-mediated quorum sensing mechanisms, known as
quorum quenching, aims to shut down the expression of
virulence rather than to kill the organisms. Therefore,
quorum quenching has the potential to overcome drug
related toxicities, complicating superinfections, and anti-
biotic resistance in antibiotic therapy [4,6-8].
There are several quorum-quenching strategies available
for disrupting the AHL-based quorum-sensing microor-
ganisms, including the enzymatic inactivation of AHL
molecules and the inhibition of AHL synthesis by tri-
closans [9,10]. Another strategy is to block the formation
of LuxR/AHL complexes by using halogenated furanones
[11]. However, the major quorum-quenching approach
for controlling AHL-regulated disease focuses on the AHL-
lactonases and AHL-acylases [12]. AHL-acylases degrade
AHLs by hydrolysing the amide linkages between the fatty
acid chain and the homoserine lactone moiety [13]. To
date, only five AHL-acylase genes, i.e. aiiD in Ralstonia sp
XJ12B [14], ahlM in Streptomyces sp. M664 [13], pvdQ and
quiP in P. aeruginosa PAO1 [15-17], and aiiC in Anabaena
sp. PCC7120 [18] have been identified.
Interestingly, the human opportunistic pathogen P. aeru-
ginosa PAO1 produces two major AHLs, including N-(3-
oxo-dodecanoyl)-homoserine lactone (3OC12-HSL) and
N-butanoyl-homoserine lactone (C4-HSL) [19-21], as
well as an AHL-acylase PvdQ; this seemingly different
from the common single set of the luxI/luxR homologue
system.  P. aeruginosa PAO1 possesses a more complex
hierarchical AHL mediated quorum-sensing mechanism
that is composed of two sets of luxI/luxR homologues,
termed lasR/lasI and rhlR/rhlI systems [19]. These systems
are first operated by 3OC12-HSL and C4-HSL, respec-
tively; furthermore, the lasR/lasI system can regulate the
rhlR/rhlI  system at the transcriptional and post-transla-
tional levels [20,21]. It has been reported that the PvdQ
acylase degrades only AHLs with long acyl-chains
(3OC12-HSL) and not those with short acyl-chains (C4-
HSL) [16]. The co-existence of AHLs with an AHL-degrad-
ing enzyme in P. aeruginosa PAO1 has been suggested for
fine-tuning the expression of virulent genes by manipulat-
ing the ratios of their two AHL signals [12].
Ralstonia solanacearum is an important soil-borne plant
pathogen with an extensive host range. It generally
causes severe bacterial wilt disease in many economic
crops, including tomato, potato, tobacco, peanut, and
banana [22]. R. solanacearum utilizes a complex hierar-
chical PhcA regulatory network to control its virulence
factors [23]. The PhcA as the central transcriptional reg-
ulator in this global regulation network is modulated by
3-OH-palmitic acid methyl ester (3-OH-PAME) [24,25].
R. solanacearum also possesses a solI/solR quorum-sens-
ing system that is a luxI/luxR homologue and is up-regu-
lated by 3-OH-PAME [26]. Inactivation of solIR
eliminates the synthesis of C6- and C8- HSLs, but does
not affect disease or virulence factor production. At least
one gene, aidA with unknown function, is activated by
solR [25]. The role of AHLs in R. solanacearum gene regu-
lation requires much further investigation. However, no
report concerning any AHL-degrading enzyme from R.
solanacearum has been published so far. In this study, an
undemonstrated function of the aac  sequence of R.
solanacearumGMI1000 homologous to the AiiD acylase
was cloned and characterised. The potential of AHL-
degrading enzyme is also discussed here.
Methods
Bacterial strains, culture media, and conditions
All bacterial strains and plasmids used in this study are
listed in Table 1. The bioassay strain of C. violaceum
CV026 [27] used is mini-Tn5 mutant derived from the
wild type strain C. violaceum ATCC 31532 and defective in
C6-HSL production. E. coli DH10B (Invitrogen Ltd, Cali-
fornia, USA) was used as a blue-white screening host. E.
coli BL21(DE3) (Novagen Ltd, Wisconsin, USA) was used
as a host for large scale protein expression. E. coli
CA027ZC09 that harbours pZC09 as the R.
solanacearumGMI1000 aac gene donor was used to per-
form gene cloning [28]. C. violaceum and E. coli were cul-
tured in Luria Bertani (LB) broth or LB agar plates at 30°C
and 37°C, respectively. Candida tropicalis F-129 [29] was
cultured in LB broth at 37°C for minimum inhibitory
concentration (MIC) tests. When required, antibiotics
were incorporated into the growth medium in the follow-
ing concentrations: ampicillin (100 μg·ml-1), tetracycline
(10 μg·ml-1), kanamycin (50 μg·ml-1), and streptomycin
(10 μg·ml-1).BMC Microbiology 2009, 9:89 http://www.biomedcentral.com/1471-2180/9/89
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In vitro whole cell bioassay for AHL-degrading activity
The bioassay was modified from the method used for the
isolation of AHL-degrading Streptomyces strains [13]. For
preparation of the well plate [27], 10 ml of LB agar con-
taining 1.5% agar was seeded with 1 ml of C. violaceum
CV026 overnight culture, and then immediately poured
over the surface of solidified LB agar. After the overlaid
agar solidified, several wells were punched on the top of
the LB agar to form the well plate. For preparation of the
whole cell reaction mixture, 1 ml of E. coli clone overnight
culture was centrifuged and suspended in 1 ml of 100 mM
Tris buffer (pH 7.0). Then, 150 μl of the cell suspension
(OD600 = 1.2) was mixed with an equal volume of 25 μM
N-(heptanoyl)-L-homoserine lactone (C7-HSL) or C8-
HSL (Fluka Ltd, SG, Switzerland) and incubated at 30°C,
with gentle agitation, for 1 h. The whole cell reaction mix-
ture was boiled (95°C, 5 min) to stop the enzymatic reac-
tion. One hundred microlitres of the reaction mixture was
loaded into the well on the plate. The loaded bioassay
plate was finally incubated in the upright position at 30°C
for 24 h to observe whether adequate colour development
was achieved. A violet pigmentation of the bacterial lawn
distributed around the wells indicated an absence of AHL-
degrading activity.
Cloning and expression of aac gene
The plasmid DNA pZC09, carrying the aac gene, was pre-
pared by using Gene-Spin Miniprep Purification Kit (Pro-
tech Ltd, Taiwan) and used as a PCR template. The aac
gene was amplified by PCR with primers, 5'-GAGGTAC-
CGAAGGAGGACACCGCATG-3' (forward) and 5'-
CGACTAGTTCACTGCGACAGCTTTGTCACCT-3' (the
KpnI and SpeI sites are underlined, the start and stop
codons are in italic, the RBS site is in bold font). Template
DNA (10 ng) was added to the PCR reactions at a final
reaction volume of 50 μl (1× DyNAzyme II buffer, 200 μM
deoxynucleotide triphosphate, 1.0 μM primer, 2% dime-
thyl sulfoxide (Sigma Ltd, MO, USA), and 5.0 U
DyNAzyme™ II DNA polymerase (Finnzymes Ltd,
ESPOO, Finland). PCR was performed in a GeneAmp PCR
system 9700 (Perkin Elmer Ltd, CA, USA). The PCR prod-
ucts were digested with KpnI and SpeI and then purified by
a PCR-M™ Clean Up System kit (Viogene Ltd, Taiwan).
Eighty ng of the purified PCR product was added into 15
μl of the ligation mixture (50 ng of KpnI/SpeI-digested
pBBR1MCS-3, 1× ligation buffer, and 5 U T4 DNA ligase)
and incubated at 16°C for 16 h. The resulting construct,
pS3aac, was transformed into E. coli DH10B by the heat
shock method [31] and screened on LB agar containing
tetracycline (10 μg·ml-1), isopropyl-β-D-thiogalactopyra-
noside (IPTG, 50 μg·ml-1), and 5-bromo-4-chloro-3-
indolyl-D-galactoside (X-Gal, 50 μg·ml-1). Then, the pos-
itive clones of E. coli DH10B (pS3aac) expressing AHL-
degrading activity were identified through the in vitro
whole cell bioassay. Next, the cloned aac  gene was
sequenced by an ABI PRISM 3730XL DNA Analyzer along
with an ABI PRISM BigDye Terminator Cycle Sequencing
Ready Reaction Kit (Perkin-Elmer).
Preparation of crude Aac proteins
The aac gene was amplified by PCR with the primers 5'-
CGCAGAATTCATGACGCACGGATTC-3' (the EcoRI site is
underlined) and 5'-CGGCAAGCTTCTGCGACAGCTTTG-
3' (the HindIII site is underlined), and then ligated to vec-
tor pET21a (Novagen). The resultant pET21aac was trans-
formed into the expression host E. coli BL21(DE3). One
ml of cultured E. coli BL21 (pET21aac) (OD600 = 0.6) were
induced by using 1.0 mM IPTG for 20 h at 20°C. The har-
Table 1: Bacterial strains and plasmids used in this study
Strain or plasmid Genotype or Descriptiona Reference
Strains
C. violaceum CV026 White indicator strain; cviI::Tn5 xylE; Ampr, Kanr, Strr, Tets, Erys, Chls 27
E. coli CA027ZC09 The genomic clone generated from Ralstonia solanacearum GMI1000 for sequencing harbor plasmid pZC09 
containing aac gene (RSc2547); Ampr
INRA-CNRSb
E. coli DH10B F-mcrAΔ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 deoR recA1 endA1 araΔ139 Δ(ara leu)7697 galU galK 
λ-rpsL nupG; Strr
Invitrogen
E. coli BL21(DE3) hsdS gal (λcIts857 ind1 Sam7 nin5 lacUV5-T7 gene 1) Novagen
Candida tropicalis F-129 Test strain for the MIC of aculeacin A assay 29
Plasmids
pZC09 Plasmid generated from Ralstonia solanacearum GMI1000 for sequencing project from which the aac gene 
was amplified; Ampr
INRA-CNRSb
pBBR1MCS-3 Mobilisable broad-host-range cloning vector; low copy number; mol, rep, lacZ; Tetr 30
pS3aac Transcriptional fusion of aac gene in pBBR1MCS-3; Tetr This study
pET21a Expression vector; T7 promoter; C-terminal HisTag; lacI; Ampr Novagen
pET21aac Translational fusion of aac gene in pET21a; Ampr This study
a Amp: ampicillin; Kan: kanamycin; Tet: tetracycline; Nal: nalidixic acid; Str:
streptomycin; Chl: chloramphenicol; Ery: erythomycin
b INRA-CNRS: Laboratoire de Biologie Moleculaire des Relations Plantes
Microorganismes INRA-CNRS, FranceBMC Microbiology 2009, 9:89 http://www.biomedcentral.com/1471-2180/9/89
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vested cells were resuspended in 0.5 ml of 50 mM sodium
phosphate (pH 7.0) and then broken by ultrasonification
for 1 min (pulse on, 0.8 s; pulse off, 0.2 s) with a Sonica-
tor® (Heat System, Taiwan). The total proteins were ana-
lysed by 6% sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE).
ESI-MS analysis
To analyse the degradation products of C7-HSL that were
digested by E. coli (pS3aac), electrospray ionization mass
spectrometry (ESI-MS) was performed on a Q-Tof
Ultima™ API equipped with a nano-spray Z-spray source
(Micromass, UK). One ml of E. coli (pS3aac) cells (OD600
= 1.2) was washed three times and suspended in 1 ml of
100 mM sodium phosphate buffer (pH 7.0) containing
either 0.5 mM C7-HSL or 10 mM ammonia acetate buffer
(pH 7.0) containing 0.5 mM C7-HSL, and then each sam-
ple was incubated at 30°C for 1 h. The reaction mixtures
were centrifuged at 13,000 rpm for 1 min and then the
supernatants were collected as the analytic samples. The
analytic sample with the sodium phosphate buffer was
diluted 100-fold with 0.018% triethylamine (pH 7.0)
containing 40% acetonitrile and 10% methanol and was
then ionised by positive-ion electrospray (ESI+-MS) to
detect HSL. The analytic sample with the ammonia acetate
buffer was diluted 10-fold with 50% methanol and then
ionised by negative-ion electrospray (ESI--MS) to detect
heptanoic acid. In order to analyse the degradation prod-
ucts of aculeacin A, i.e. palmatic acid, 40 μl of Aac-
digested mixture (6 μg of aculeacin A and 7.2 μg of puri-
fied Aac in 10 mM ammonia acetate) was diluted with 40
μl of 50% acetonitrile containing 0.1% formic acid and
then detected by ESI+-MS.
In this study, we used the following condition for ESI-MS.
Approximately 400 nl/min analyte flow rate was used
with the Q-Tof instrument. The cone and capillary voltage
was set to 135 V and 3.5 KV, respectively, and the source
block and desolvation temperature was 80°C and 150°C,
respectively. The range of m/z value was set to 50 ~500
since this was sufficient for all of degraded products. Data
was analyzed by MassLynx 4.0 software (Micromass, UK).
HSL-OPA assay for AHL-acylase activity
A modified homoserine lactone-o-phthaldialdehyde
(HSL-OPA) assay was used to quantify the AHL-acylase
activity [13]. Seven AHLs (Fluka Ltd, SG, Switzerland)
were used as substrates of AHL-acylase. Various AHL-
degrading products were collected using the preparation
method of the analytic sample in the sodium phosphate
buffer, as described in ESI-MS analysis. One hundred μl of
each AHL-degrading product was immediately mixed
with 100 μl of o-phthaldialdehyde reagent solution (OPA,
Sigma), and then the mixture was incubated for 2 min at
25°C to prepare the fluorescent derivative of the released
HSL. The absorbance of OPA-derivatives was measured at
OD340 using a U-2000 spectrophotometer (Hitachi Ltd,
Tokyo, Japan). A standard HSL with a range of 0.1 ~1 mM
was used to calibrate the assay and render a linear correla-
tion: OD340 = 0.0014 [HSL] (r2 = 0.99). One unit of the
AHL-acylase activity is defined as the released nmol
amount of HSL after an AHL is digested by 1 ml of cell sus-
pension (OD600 = 1.2, cell density reaches 3 × 107 CFU ml-
1) at 30°C for 1 min.
Violacein quantitative assay
To observe the in vivo expression of the aac gene in C. vio-
laceum, the pS3aac was transformed to C. violaceum
CV026 by the heat shock method [31] and a violacein
quantitative assay [32] was performed. One ml of cultured
C. violaceum CV026 (pS3aac) (OD600 = 0.7) was added
into 100 ml of fresh LB broth containing tetracycline and
0.5 mM C7-HSL, and then incubated at 30°C at 250 rpm
for 24 h. At intervals of 2 h, the violacein from 0.5 ml of
various interval cells was extracted with 1 ml of 95% eth-
anol for 1 min. The supernatant containing the violacein
was collected by centrifuging at 13,000 rpm for 1 min. The
absorbance of the supernatant was measured at a wave-
length of 576 nm (OD576) using a U-2000 spectropho-
tometer (Hitachi).
Chitinase activity assay
The chitinolytic activity assay was modified from the
method for detecting chitinolytic activity on agar plates
[33]. Cells were seeded on LB agar containing tetracycline
(10 μg·ml-1), 0.5 mM C7-HSL, and 0.2% (w/v) chitin
from crab shells (Sigma). The plate was incubated at 30°C
for 3 ~5 d to observe whether a clear zone formed around
the colonies. The formation of a clear zone indicated a
positive reaction.
Minimal inhibitory concentration (MIC) of aculeacin A
The assay for the determination of MIC values of
aculeacin A was modified from the dilution susceptibility
test [34]. A series of samples of 10 ml LB broth containing
either aculeacin A or Aac-treated aculeacin A with concen-
trations in the range of 0–1 μg·ml-1 was prepared and
inoculated with 100 μl of 16 h pre-cultured Candida trop-
icalis F-129 and incubated at 37°C for 16 h. The growth of
the cells was measured at OD600. Serial dilutions of
aculeacin A were incubated with 12 μg of purified Aac in
90 μlof sodium phosphate (pH 7.0) at 30°C for 1.5 h;
subsequently, the dilution susceptibility test was per-
formed.
Bioinformatics
The first cloned AHL-lactonase gene aiiA  [35] and the
AHL-acylase gene aiiD  [14] were utilised as the target
genes in the BLASTN and BLASTP programs [36,37] at
NCBI. Several public R. solanacearumGMI1000 genomicBMC Microbiology 2009, 9:89 http://www.biomedcentral.com/1471-2180/9/89
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clones containing the aac  gene were searched by the
GMI1000 clone finder. http://bioinfo.genopole-tou
louse.prd.fr/annotation/iANT/bacteria/ralsto/index.html.
Statistics
The Microsoft Excel 2003 t-test program was used.
Results
Identification of candidate AHL-degrading enzymes 
encoded by R. solanacearumGMI1000
BLASTN and BLASTP searches of the annotated R.
solanacearumGMI1000 genome sequence (NC 003295)
and megaplasmid pGMI1000MP (NC003296) [28] iden-
tified a single 2,388-bp aac gene (Locus tag RSc2547) with
an 83% identity match when interrogated with the AHL-
acylase  aiiD  sequence [14]. No significant hits were
obtained with the AHL lactonase aiiA  sequence [35].
However, the aac gene encodes a putative protein that was
defined as a probable aculeacin A acylase transmembrane
protein (NP 520668). Among the function-demonstrat-
ing proteins, Aac shared 83%, 39%, 24%, and 24% iden-
tities at the peptide level with the AHL-acylase from
Ralstonia sp. XJ12B [14], aculeacin A acylase from Actino-
planes utahensis [38], cephalosporin acylase from Brevundi-
monas diminuta [39], and Penicillin G acylase from
Providencia rettgeri [40], respectively.
Cloning and expression of the aac gene of R. 
solanacearumGMI1000
The aac gene was PCR amplified (refer to Materials and
Methods) and the 2,405 bp product was cloned in
pBBR1MCS-3 to yield plasmid pS3aac. To analyse the
ability of Aac to degrade AHLs pS3aac was used to trans-
form E. coli DH10B. The cloned aac sequence was con-
firmed to have no mutations. For examining the
degrading activity of the clone E. coli DH10B (pS3aac),
C6-, C7-, and C8- HSLs were used as autoinducers in per-
forming a whole cell bioassay described in the Materials
and Methods. The results of the whole cell bioassay
revealed that E. coli DH10B (pS3aac) cells were inactive
against C6-HSL while active against C7- and C8-HSLs
(Table 2). Since the vector pBBR1MCS-3 does not contain
lacI, we considered that E. coli DH10B (pS3aac) cells
exhibit C7- and C8-HSLs degrading activities inrespective
of the presence or absence of IPTG induction (Table 2).
Because C7-HSL was a more sensitive AHL than C8-HSL
(data not shown), we chose C7-HSL for inducing C. viol-
aceum CV026 to produce violacein in whole cell bioassay
(Fig. 1, well 1). The cells of E. coli DH10B (pS3aac) exhib-
ited C7-HSL degrading activity (Fig. 1, well 3), while no
activity was observed in the cell-free culture supernatant
of E. coli DH10B (pS3aac) (Fig. 1, well 4). This data indi-
cated that the protein encoded by the aac gene is a cell
associated AHL-degrading enzyme. The aac  gene was
fused into pET21a to yield plasmid pET21aac, and then
over expressed in E.coli BL21(DE3) from an inducible pro-
moter. The SDS-PAGE analysis demonstrated that the
IPTG-induced total proteins contained a polypeptide with
a molecular mass of 88 kDa that was consistent with the
824 residues Aac-fused protein that had a predicted
molecular mass of 88,645 Da (Fig. 2).
Aac is an AHL-acylase and not an aculeacin A acylase
To demonstrate whether the Aac protein is an AHL-acy-
lase, we performed the ESI-MS analysis. E. coli DH10B
(pS3aac) cells were first reacted with C7-HSL at 30°C for
60 min. If the enzyme encoded by the aac gene is an AHL-
acylase, we predicted that two free digested products, HSL
and heptanoic acid, would be detected. Since ESI+-MS
could not detect the carboxylic group (COO-), only HSL
was detectable. The fatty acids containing the carboxylic
group would have to be detected by ESI--MS. The analytic
results showed that C7-HSL (M+H m/z = 214) could be
digested into HSL (M+H m/z = 102) and heptanoic acid
(M-H  m/z  = 129) (Fig. 3). We also observed that the
amount of the heptanoic acid gradually increased, starting
from the 15th min until the 60th min of reaction times
(data not shown). Thus, our results indicate that the aac
gene encodes an AHL-acylase.
Table 2: The AHL-degrading abilities of E. coli DH10B (pS3aac) evaluated by whole cell bioassay
AHL-degrading abilitiesa
C6-HSL C7-HSL C8-HSL
Test strains IPTG(+) IPTG(-) IPTG(+) IPTG(-) IPTG(+) IPTG(-)
CSCS CSCS CSCS
E. coli DH10B (pBBR1MCS-3) -- -- -- -- -- --
E. coli DH10B (pS3aac) -- -- + - + - + - + -
a The whole cells (C) and cell-free supernatants (S) of test strains, were prepared from the 0.4 mM IPTG induced and uninduced cultures, and then 
reacted with various AHLs to perform whole cell bioassays. Identical to the result in Fig. 1, the absence of a violet lawn indicates a positive AHL-
degrading ability and is defined as'+'; a violet lawn indicates no AHL-degrading ability and is defined as'-'BMC Microbiology 2009, 9:89 http://www.biomedcentral.com/1471-2180/9/89
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Since Aac was predicted as a probable aculeacin A acylase
transmembrane protein, we compared the MICs of
aculeacin A and Aac-treated aculeacin A in order to deter-
mine whether the Aac protein functioned similar to
aculeacin A acylase. As shown in Table 3, the MICs of both
aculeacin A and Aac-treated aculeacin A for Candida tropi-
calis F-129 were 0.05 μg·ml-1. In addition, the predicted
Aac-digested products of aculeacin A, i.e. palmatic acid
(M+H m/z = 257), were not found in the ESI-MS analysis
(data not shown). These results revealed that Aac is not an
aculeacin A acylase.
Aac is active against AHLs with acyl side chains greater 
than 6 carbons
To determine the substrate specificity and enzymatic activ-
ity of the AHL-acylase Aac in E. coli DH10B (pS3aac), a
range of AHLs were mixed with cells of E. coli DH10B
(pS3aac) to perform the HSL-OPA assay. As shown in
Table 4, E. coli DH10B (pS3aac) could not degrade the
short-chain AHLs, C4-, C6-, or 3OC6-HSLs; however, E.
coli  DH10B (pS3aac) exhibited activities against long-
chain AHLs, C7-, C8-, 3OC8-, C10-HSLs. The AHLs of
more than ten carbon-acyl chains, i.e. C12-HSL and C14-
HSL, could not be determined due to the poor solubility
of their substrate. These results indicate that the substrate
specificity of the AHL-acylase Aac is within the limit of
more than six carbon-acyl chain AHLs.
Expression of the aac gene in C. violaceum CV026 
inhibited the production of violacein and chitinase activity 
that were observed in the AHL-mediated phenotype
To examine whether the aac  gene has the potential of
being a quorum-quenching agent, an AHL regulated
strain, C. violaceum CV026, was used as a target microor-
ganism. The mutant C. violaceum CV026 cannot produce
violacein unless provided with exogenous AHL [27].
Therefore the pS3aac was transformed into C. violaceum
CV026 to observe whether violacein production was
reduced during culture with exogenous AHL. As shown in
Fig. 4A, the result indicates that the expression of the aac
gene did not influence the growth of C. violaceum CV026
during the late exponential phase but slightly influenced
its growth during the stationary phase. Interestingly, C.
violaceum CV026 (pBBR1MCS-3) produced violacein after
the late exponential phase, while C. violaceum CV026
(pS3aac) completely failed in producing violacein (Fig.
4B). Since it was reported that chitinases could be regu-
lated by endogenous C6-HSL in C. violaceum ATCC 31532
[33], we decided to evaluate the chitinolytic activity of C.
The Aac acylase degrades C7-HSL in C. violaceum CV026 cul- tures and inhibits violacein production Figure 1
The Aac acylase degrades C7-HSL in C. violaceum 
CV026 cultures and inhibits violacein production. The 
E. coli DH10B (pS3aac) overnight culture was centrifuged, 
and the harvested cells were suspended into 100 mM Tris 
buffer (pH 7.0). The cell suspensions and cell free superna-
tants were mixed with 25 μM C7-HSL each and then incu-
bated at 30°C for 1 h. The mixtures were assayed by the in 
vitro whole cell bioassay. Well 1, C7-HSL (AHL-non-degrad-
ing control); well 2, Tris buffer (AHL-degrading control); well 
3, the mixture of cell suspensions with C7-HSL; well 4, the 
mixture of supernatants with C7-HSL.
SDS-PAGE analysis Aac expressed by E. coli BL21(DE3) Figure 2
SDS-PAGE analysis Aac expressed by E. coli 
BL21(DE3). The crude proteins were prepared from the 
recombinant E. coli BL21 (pET21aac) and analysed by 6% 
SDS-PAGE. The arrow indicates the Aac. Lane 1, pre-stained 
protein ladder marker; lane 2, IPTG-induced crude proteins; 
lane 3, IPTG-non-induced crude proteins.
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ESI-MS spectrometry analysis of C7-HSL degradation by AHL-acylase Aac Figure 3
ESI-MS spectrometry analysis of C7-HSL degradation by AHL-acylase Aac. The E. coli DH10B (pS3aac) cells were 
suspended in 0.1 mM sodium phosphate and 0.01 mM ammonia acetate, respectively, and then mixed with 25 μM C7-HSL for 
the degradation reaction described in Materials and Methods. (a) To detect HSL, the ESI+-MS spectra of undigested C7-HSL 
(top) and degraded C7-HSL products (bottom) were shown. (b) To detect heptanoic acid, the ESI--MS spectra of undigested 
C7-HSL (top) and degraded C7-HSL products (bottom) were shown. (c) Mechanism of C7-AHL degradation by Aac. The white 
arrow indicates the Aac catalytic site.
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violaceum  CV026 (pS3aac). C. violaceum CV026
(pBBR1MCS-3) was able to form clear zones on LB agar
containing tetracycline, chitin, and C7-HSL. However, no
clear zone were observed around the C. violaceum CV026
(pS3aac) colonies (Fig. 4C). These results indicated that
transferring the aac gene into C. violaceum CV026 signifi-
cantly inhibited violacein production and chitinase activ-
ity.
Discussion
We successfully subcloned and identified an aac gene (NP
520668) from R. solanacearumGMI1000 as an AHL-acy-
lase that did not degrade aculeacin A, ampicillin, and
ceftazidime (data not shown). The amino acid sequence
of Aac is similar to that of AHL-acylase from Ralstonia sp.
XJ12B (Ralstonia eutropha) with 83% identity. However,
this is the first study to report the presence of an AHL-acy-
lase in a phytopathogen.
To verify the existence of an AHL-acylase, both gas chro-
matography assays [16] and HPLC-ESI-MS analyses
[13,14] are generally used to analyse the digested AHL
products. Our report provides a simple and rapid ESI-MS
analysis to verify AHL-acylase. To identify an AHL-acylase,
two target products, the released HSL and the correspond-
ing fatty acid, were detected when the AHL was digested
by the AHL-degrading clone. Since the released fatty acids
would be further metabolized by β-oxidation during cul-
tivation [41], excessively long digestion times should be
avoided. The digestion mixture was directly used as a sam-
ple to perform ESI-MS analysis. The reaction buffers were
observed to have a decisive effect on ESI-MS analysis.
When 100 mM sodium phosphate (pH 7.0) was used as a
reaction buffer, only the phosphate ([M-H] m/z = 97) was
found in the ESI--MS pattern, wherein the fatty acid was
still not detectable (data not shown). In contrast, when 10
mM ammonia acetate was used as a reaction buffer to
avoid the phosphate effect, the fatty acid was detected by
ESI--MS (Fig. 3B).
Among the reported AHL-acylases, only AiiC can dea-
cylate the short chain C6-HSL [18]. In addition, PvdQand
QuiP were verified to express C7-HSL-degrading activity.
However, the substrate specificity of the Aac for AHLs is
within the limits of more than six carbon-acyl chain
(Table 4). Moreover, transferring the aac gene into C. vio-
laceum CV026 significantly influenced violacein produc-
tion and chitinase activity (Fig. 4). These results indicated
that Aac has the potential to be a quorum- quenching
agent.
Although the quorum-sensing signal for controlling the
virulence factors of R. solanacearum is 3-OH-PAME, solI
and solR are members of the 3-OH-PAME communication
system regulon [25]. In our study, no 3-OH-PAME-
degrading enzyme has been found using the BLASTP
search when interrogated with the beta-hydroxypalmitate
methyl ester hydrolase (BAF64544) [42]. There are SolI
(NP 521405) and SolR (NP 521406) proteins of R.
solanacearumGMI1000 sharing 86% and 87% identity,
respectively, with that of SolI (O30920) and SolR
(AAC45947) from R. solanacearumAW1. Because the SolI
(O30920) synthesizes C6- and C8-HSLs, the GMI1000
strain might be expected to produce both of them.
Although the physiological role of AHL-acylase in R.
solanacearum  is unclear yet, we consider that R.
solanacearum might adopt a unique signal turnover system
to control existing signals from a quorum-sensing mode
Table 3: The minimal inhibitory concentrations of aculeacin A for Candida tropicalis F-129
OD600
a at serial diluted aculeacin A (μg·ml-1)
Aculeacin A 0 0.001 0.005 0.01 0.05 0.1 0.5 1
Untreated 0.592 ± 0.036* 0.615 ± 0.088* 0.255 ± 0.096* 0.126 ± 0.029* 0.045 ± 0.006 0.047 ± 0.008 0.043 ± 0.002 0.041 ± 0.004
Aac treated 0.629 ± 0.032* 0.634 ± 0.047* 0.297 ± 0.030* 0.093 ± 0.017* 0.070 ± 0.035 0.054 ± 0.007 0.044 ± 0.002 0.042 ± 0.005
a Values represent the averages ± standard errors from triplicate independent assays. By one-tailed student's t-test (P < 0.05), the value with an 
asterisk (*) designates a significant difference from the 1 μg·ml-1 of aculeacin A test shown in the same row. There is no significant difference 
between Aac-untreated aculeacin A and Aac-treated aculeacin A in the same column
Table 4: Substrate specificities of the AHL-acylase Aac against 
AHLs
AHL-acylase activities (nmol·min-1·ml-1)a
AHLs E. coli DH10B (pBBR1MCS-3) E. coli DH10B
(pS3aac)
C4-HSL 0.26 ± 0.15 (7.2%) 0.37 ± 0.13 (10.3%)
C6-HSL 0.31 ± 0.15 (8.7%) 0.38 ± 0.10 (10.5%)
3OC6-HSL 0.37 ± 0.09 (10.5%) 0.35 ± 0.09 (10.5%)
C7-HSL 0.23 ± 0.15 (6.4%) 3.60 ± 0.31 (100.0%)*
C8-HSL 0.21 ± 0.16 (5.7%) 1.63 ± 0.21 (45.4%)*
3OC8-HSL 0.22 ± 0.17 (6.1%) 2.56 ± 0.04 (71.1%)*
C10-HSL 0.25 ± 0.15 (7.1%) 3.10 ± 0.25 (86.1%)*
a Values represent the averages ± standard errors from triplicate 
independent HSL-OPA assays. The relative activity in parentheses is 
based on defining C7-HSL-degrading activity exhibited by E. coli 
DH10B (pS3aac) as 100%. The value with an asterisk (*) is the 
significant difference from the E. coli DH10B (pBBR1MCS-3) shown in 
the same row by one-tailed Student's t-test (P < 0.05)BMC Microbiology 2009, 9:89 http://www.biomedcentral.com/1471-2180/9/89
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The effects of Aac on the production of violacein and chitinase activity in C. violaceum CV026 Figure 4
The effects of Aac on the production of violacein and chitinase activity in C. violaceum CV026. The plasmids 
pBBR1MCS-3 and pS3aac were transformed into C. violaceum CV026. Both of them were cultivated in LB containing tetracy-
cline as well as 25 μM C7-HSL. (a) Cell growth was monitored by measuring the OD600. (b) The violacein production was 
determined by OD576 during growth. The data represent the mean values of three independent experiments. (c) The overnight 
cultures of C. violaceum CV026 (pS3aac) and C. violaceum CV026 (pBBR1MCS-3) (no aac insert) were seeded onto an LA plate 
containing tetracycline, C7-HSL and chitin in order to assay the chitinolytic activity. The plates were incubated at 30°C for 5 d. 
The formation of a clear zone around the colonies indicated positive chitinolytic activity.
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[43]. The AHL-acylase would be a mechanism of interfer-
ence to degrade exogenous signals produced by competi-
tors. It may also be possible that these acylase prevent the
accumulation of self generated signals, allowing the quo-
rum response to switch off as is seen in Agrobacterium
tumefaciens [43].
Recently, several reports indicated that quorum-quench-
ing enzymes, such as lactonase, AHL-acylase, and oxidore-
ductase, have potential to be used as peptide drugs.
Among them, AHL-lactonase has been applied in geneti-
cally engineered procedures to control plant diseases
[35,44]. Eventually such enzymes would lead to the atten-
uation of the expression of quorum-sensing regulated
functions in microorganisms. AHL-lactonases will alter
the AHLs structure, thus mediating pH-dependent lac-
tonolysis; however, lactonases-inactivated AHLs could be
readily reverted to the active forms with lactone-ring clo-
sure [45]. This drawback would interfere with the devel-
opment of AHL-lactonase as peptide drugs. Since AHL-
acylases have none of the drawbacks described above, Aac
could become a potential quorum-quenching agent in the
near feature.
Conclusion
This paper describes the identification of AHL-acylase,
Aac, from R. solanacearumGMI1000 with ESI-MS mass
spectrometry analysis and whole cell bioassay, together
with the analysis of MIC test of aculeacin A. The results
showed strong evidence that the Aac in R.
solanacearumGMI1000 functions as an AHL-acylase and
not an aculeacin A acylase. Thus, we consider that renam-
ing the aac gene of R. solanacearumGMI1000 as "the alaS
gene" is necessary in further studies for the purpose of
clarity. Moreover, this is the first report to find an AHL-
acylase in a phytopathogen.
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